Cargando…
Dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969341/ https://www.ncbi.nlm.nih.gov/pubmed/27306615 http://dx.doi.org/10.1007/s00125-016-4017-1 |
| _version_ | 1782445767848361984 |
|---|---|
| author | Fioretto, Paola Stefansson, Bergur V. Johnsson, Eva Cain, Valerie A. Sjöström, C. David |
| author_facet | Fioretto, Paola Stefansson, Bergur V. Johnsson, Eva Cain, Valerie A. Sjöström, C. David |
| author_sort | Fioretto, Paola |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4969341 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-49693412016-08-17 Dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment Fioretto, Paola Stefansson, Bergur V. Johnsson, Eva Cain, Valerie A. Sjöström, C. David Diabetologia Research Letter Springer Berlin Heidelberg 2016-06-15 2016 /pmc/articles/PMC4969341/ /pubmed/27306615 http://dx.doi.org/10.1007/s00125-016-4017-1 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Research Letter Fioretto, Paola Stefansson, Bergur V. Johnsson, Eva Cain, Valerie A. Sjöström, C. David Dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment |
| title | Dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment |
| title_full | Dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment |
| title_fullStr | Dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment |
| title_full_unstemmed | Dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment |
| title_short | Dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment |
| title_sort | dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969341/ https://www.ncbi.nlm.nih.gov/pubmed/27306615 http://dx.doi.org/10.1007/s00125-016-4017-1 |
| work_keys_str_mv | AT fiorettopaola dapagliflozinreducesalbuminuriaover2yearsinpatientswithtype2diabetesmellitusandrenalimpairment AT stefanssonbergurv dapagliflozinreducesalbuminuriaover2yearsinpatientswithtype2diabetesmellitusandrenalimpairment AT johnssoneva dapagliflozinreducesalbuminuriaover2yearsinpatientswithtype2diabetesmellitusandrenalimpairment AT cainvaleriea dapagliflozinreducesalbuminuriaover2yearsinpatientswithtype2diabetesmellitusandrenalimpairment AT sjostromcdavid dapagliflozinreducesalbuminuriaover2yearsinpatientswithtype2diabetesmellitusandrenalimpairment |